Table 1

Summary of the patient demographics and outcomes for the incoming and outgoing cohorts

Incoming
LT unit (n)Age (median and range (if applicable)) and disease (number, %)Reason for initial centre not listing (number, %)Outcome from second opinion (number, %)If listed, outcome
A (n=17)52 (27–66)
ArLD (12, 71%)
NASH (4, 24%)
AIH (1, 5%)
Alcohol risk (5, 30%)
Medical/anaesthetic risk (10, 59%)
Other (2, 11%)
Not assessed (8, 47%)
Discussion in principle, declined (3, 18%)
Assessed, not listed (6, 35%)
N/A
B (n=3)53 (36–66)
ArLD (2, 66%)
NAFLD (1, 33%)
Alcohol risk 2, (66%)
Medical/anaesthetic risk (1, 33%)
Not assessed (2, 66%)
Assessed, not listed (1, 33%)
N/A
C (n=1)72
ArLD
Alcohol riskAssessed, listedTransplanted
D (n=1)66
NASH
Medical/anaesthetic riskAssessed, listedListed, subsequently removed
E (n=1)43
ArLD
Alcohol riskAssessed, listedAwaiting LT
  • Data are reported with median and range for continuous variable, n and % for categorical variables.

  • AIH, autoimmune hepatitis; ArLD, alcoholic related liver disease; LT, liver transplantation; N/A, not available; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.